Lilly's experimental drug cuts weight by 21% in diabetes trial

FILE PHOTO: The Eli Lilly logo is shown at the BIO International Convention 2026, a meeting of pharmaceutical and biotechnology leaders in San Diego, California, U.S. June 23, 2026.

FILE PHOTO: The Eli Lilly logo is shown at the BIO International Convention 2026, a meeting of pharmaceutical and biotechnology leaders in San Diego, California, U.S. June 23, 2026. (REUTERS/Mike Blake/File Photo)


1 photo
Save Story

Estimated read time: Less than a minute

Sept 29 — ​Eli Lilly said ‌on Tuesday ⁠its ​experimental ⁠drug ‌helped adults ‌with type ⁠2 ⁠diabetes and obesity lose an ‌average ​of nearly 21% of their body ​weight ‌in ‌a late-stage ⁠clinical trial.

(Reporting by Kamal ‌Choudhury ​in ‌Bengaluru; ⁠Editing ​by Shilpi ​Majumdar)

Photos

Most recent Lifestyle stories

Related topics

KSL.com Beyond Series
KSL.com Beyond Business

KSL Weather Forecast

KSL Weather Forecast
Play button